260 related articles for article (PubMed ID: 15095409)
1. Reduced type I collagen utilization: a pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome.
Wenstrup RJ; Florer JB; Cole WG; Willing MC; Birk DE
J Cell Biochem; 2004 May; 92(1):113-24. PubMed ID: 15095409
[TBL] [Abstract][Full Text] [Related]
2. Structural abnormalities of the cornea and lid resulting from collagen V mutations.
Segev F; Héon E; Cole WG; Wenstrup RJ; Young F; Slomovic AR; Rootman DS; Whitaker-Menezes D; Chervoneva I; Birk DE
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):565-73. PubMed ID: 16431952
[TBL] [Abstract][Full Text] [Related]
3. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients.
Malfait F; Coucke P; Symoens S; Loeys B; Nuytinck L; De Paepe A
Hum Mutat; 2005 Jan; 25(1):28-37. PubMed ID: 15580559
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetics in classic Ehlers-Danlos syndrome.
Malfait F; De Paepe A
Am J Med Genet C Semin Med Genet; 2005 Nov; 139C(1):17-23. PubMed ID: 16278879
[TBL] [Abstract][Full Text] [Related]
5. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
6. COL5A1 signal peptide mutations interfere with protein secretion and cause classic Ehlers-Danlos syndrome.
Symoens S; Malfait F; Renard M; André J; Hausser I; Loeys B; Coucke P; De Paepe A
Hum Mutat; 2009 Feb; 30(2):E395-403. PubMed ID: 18972565
[TBL] [Abstract][Full Text] [Related]
7. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
8. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito.
Toriello HV; Glover TW; Takahara K; Byers PH; Miller DE; Higgins JV; Greenspan DS
Nat Genet; 1996 Jul; 13(3):361-5. PubMed ID: 8673139
[TBL] [Abstract][Full Text] [Related]
9. Murine model of the Ehlers-Danlos syndrome. col5a1 haploinsufficiency disrupts collagen fibril assembly at multiple stages.
Wenstrup RJ; Florer JB; Davidson JM; Phillips CL; Pfeiffer BJ; Menezes DW; Chervoneva I; Birk DE
J Biol Chem; 2006 May; 281(18):12888-95. PubMed ID: 16492673
[TBL] [Abstract][Full Text] [Related]
10. Compound phenotype of osteogenesis imperfecta and Ehlers-Danlos syndrome caused by combined mutations in
Lin Z; Zeng J; Wang X
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31239369
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive study of the spatial and temporal expression of the col5a1 gene in mouse embryos: a clue for understanding collagen V function in developing connective tissues.
Roulet M; Ruggiero F; Karsenty G; LeGuellec D
Cell Tissue Res; 2007 Feb; 327(2):323-32. PubMed ID: 17024418
[TBL] [Abstract][Full Text] [Related]
12. Abnormal formation of collagen cross-links in skin fibroblasts cultured from patients with Ehlers-Danlos syndrome type VI.
Pasquali M; Still MJ; Vales T; Rosen RI; Evinger JD; Dembure PP; Longo N; Elsas LJ
Proc Assoc Am Physicians; 1997 Jan; 109(1):33-41. PubMed ID: 9010914
[TBL] [Abstract][Full Text] [Related]
13. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
[TBL] [Abstract][Full Text] [Related]
14. Homozygosity and Heterozygosity for Null Col5a2 Alleles Produce Embryonic Lethality and a Novel Classic Ehlers-Danlos Syndrome-Related Phenotype.
Park AC; Phillips CL; Pfeiffer FM; Roenneburg DA; Kernien JF; Adams SM; Davidson JM; Birk DE; Greenspan DS
Am J Pathol; 2015 Jul; 185(7):2000-11. PubMed ID: 25987251
[TBL] [Abstract][Full Text] [Related]
15. Identification of binding partners interacting with the α1-N-propeptide of type V collagen.
Symoens S; Renard M; Bonod-Bidaud C; Syx D; Vaganay E; Malfait F; Ricard-Blum S; Kessler E; Van Laer L; Coucke P; Ruggiero F; De Paepe A
Biochem J; 2011 Jan; 433(2):371-81. PubMed ID: 20979576
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive molecular analysis demonstrates type V collagen mutations in over 90% of patients with classic EDS and allows to refine diagnostic criteria.
Symoens S; Syx D; Malfait F; Callewaert B; De Backer J; Vanakker O; Coucke P; De Paepe A
Hum Mutat; 2012 Oct; 33(10):1485-93. PubMed ID: 22696272
[TBL] [Abstract][Full Text] [Related]
17. Structural in silico dissection of the collagen V interactome to identify genotype-phenotype correlations in classic Ehlers-Danlos Syndrome (EDS).
Paladin L; Tosatto SC; Minervini G
FEBS Lett; 2015 Dec; 589(24 Pt B):3871-8. PubMed ID: 26608033
[TBL] [Abstract][Full Text] [Related]
18. Regulation of collagen fibril nucleation and initial fibril assembly involves coordinate interactions with collagens V and XI in developing tendon.
Wenstrup RJ; Smith SM; Florer JB; Zhang G; Beason DP; Seegmiller RE; Soslowsky LJ; Birk DE
J Biol Chem; 2011 Jun; 286(23):20455-65. PubMed ID: 21467034
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition.
Mao JR; Taylor G; Dean WB; Wagner DR; Afzal V; Lotz JC; Rubin EM; Bristow J
Nat Genet; 2002 Apr; 30(4):421-5. PubMed ID: 11925569
[TBL] [Abstract][Full Text] [Related]
20. Abnormality of dermal collagen fibrils in Ehlers Danlos syndrome. Anticipation of the abnormality for the inherited hypermobile disorders.
Kobayasi T
Eur J Dermatol; 2004; 14(4):221-9. PubMed ID: 15319154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
